Bank Of America Corp Becton Dickinson & CO Call Options Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $2.39 Million - $2.62 Million	10,800 New	10,800 $2.6 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $630,315 - $668,871	-2,700 Reduced 44.26%	3,400 $841,000
Q4 2023 Feb 14, 2024	BUY	$232.24 - $267.23 $1.42 Million - $1.63 Million	6,100 New	6,100 $1.49 Million
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $1.9 Million - $2.11 Million	-7,800 Reduced 90.7%	800 $213,000
Q4 2021 Feb 08, 2022	SELL	$230.08 - $250.94 $25.4 Million - $27.7 Million	-110,200 Reduced 92.76%	8,600 $2.16 Million
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $25.6 Million - $28.3 Million	110,200 Added 1281.4%	118,800 $29.2 Million
Q2 2021 Sep 13, 2021	BUY	$232.65 - $254.58 $2 Million - $2.19 Million	8,600 New	8,600 $2.09 Million

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.